135 related articles for article (PubMed ID: 38224683)
1. Podocyte-specific Nup160 knockout mice develop nephrotic syndrome and glomerulosclerosis.
Li Y; Xu C; Zhao F; Liu Q; Qiu X; Li M; Yang Y; Yu S; Tong H; Zhang L; Chen B; Qu L; Yu Z
Hum Mol Genet; 2024 Apr; 33(8):667-676. PubMed ID: 38224683
[TBL] [Abstract][Full Text] [Related]
2. Mutations in
Zhao F; Zhu JY; Richman A; Fu Y; Huang W; Chen N; Pan X; Yi C; Ding X; Wang S; Wang P; Nie X; Huang J; Yang Y; Yu Z; Han Z
J Am Soc Nephrol; 2019 May; 30(5):840-853. PubMed ID: 30910934
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of NUP160 inhibits cell proliferation, induces apoptosis, autophagy and cell migration, and alters the expression and localization of podocyte associated molecules in mouse podocytes.
Wang P; Zhao F; Nie X; Liu J; Yu Z
Gene; 2018 Jul; 664():12-21. PubMed ID: 29704630
[TBL] [Abstract][Full Text] [Related]
4. Mutations in the NUP93, NUP107 and NUP160 genes cause steroid-resistant nephrotic syndrome in Chinese children.
Han Y; Sha H; Yang Y; Yu Z; Zhou L; Wang Y; Yang F; Qiu L; Zhang Y; Zhou J
Ital J Pediatr; 2024 Apr; 50(1):81. PubMed ID: 38650033
[TBL] [Abstract][Full Text] [Related]
5. Use of genomic and functional analysis to characterize patients with steroid-resistant nephrotic syndrome.
Kitzler TM; Kachurina N; Bitzan MM; Torban E; Goodyer PR
Pediatr Nephrol; 2018 Oct; 33(10):1741-1750. PubMed ID: 29982877
[TBL] [Abstract][Full Text] [Related]
6. Mutations in multiple components of the nuclear pore complex cause nephrotic syndrome.
Braun DA; Lovric S; Schapiro D; Schneider R; Marquez J; Asif M; Hussain MS; Daga A; Widmeier E; Rao J; Ashraf S; Tan W; Lusk CP; Kolb A; Jobst-Schwan T; Schmidt JM; Hoogstraten CA; Eddy K; Kitzler TM; Shril S; Moawia A; Schrage K; Khayyat AIA; Lawson JA; Gee HY; Warejko JK; Hermle T; Majmundar AJ; Hugo H; Budde B; Motameny S; Altmüller J; Noegel AA; Fathy HM; Gale DP; Waseem SS; Khan A; Kerecuk L; Hashmi S; Mohebbi N; Ettenger R; Serdaroğlu E; Alhasan KA; Hashem M; Goncalves S; Ariceta G; Ubetagoyena M; Antonin W; Baig SM; Alkuraya FS; Shen Q; Xu H; Antignac C; Lifton RP; Mane S; Nürnberg P; Khokha MK; Hildebrandt F
J Clin Invest; 2018 Oct; 128(10):4313-4328. PubMed ID: 30179222
[TBL] [Abstract][Full Text] [Related]
7. Corticosteroid treatment exacerbates nephrotic syndrome in a zebrafish model of magi2a knockout.
Jobst-Schwan T; Hoogstraten CA; Kolvenbach CM; Schmidt JM; Kolb A; Eddy K; Schneider R; Ashraf S; Widmeier E; Majmundar AJ; Hildebrandt F
Kidney Int; 2019 May; 95(5):1079-1090. PubMed ID: 31010479
[TBL] [Abstract][Full Text] [Related]
8.
Hermle T; Schneider R; Schapiro D; Braun DA; van der Ven AT; Warejko JK; Daga A; Widmeier E; Nakayama M; Jobst-Schwan T; Majmundar AJ; Ashraf S; Rao J; Finn LS; Tasic V; Hernandez JD; Bagga A; Jalalah SM; El Desoky S; Kari JA; Laricchia KM; Lek M; Rehm HL; MacArthur DG; Mane S; Lifton RP; Shril S; Hildebrandt F
J Am Soc Nephrol; 2018 Aug; 29(8):2123-2138. PubMed ID: 29959197
[TBL] [Abstract][Full Text] [Related]
9. Effects of a novel ANLN E841K mutation associated with SRNS on podocytes and its mechanism.
Lin L; Ye Y; Fu H; Gu W; Zhao M; Sun J; Cao Z; Huang G; Xie Y; Liu F; Li L; Li Q; Mao J; Hu L
Cell Commun Signal; 2023 Nov; 21(1):324. PubMed ID: 37957688
[TBL] [Abstract][Full Text] [Related]
10. Quantitative phenotyping of
Buerger F; Merz LM; Saida K; Yu S; Salmanullah D; Lemberg K; Mertens ND; Mansour B; Kolvenbach CM; Yousef K; Hölzel S; Braun A; Franken GAC; Goncalves KA; Steinsapir A; Endlich N; Schneider R; Shril S; Hildebrandt F
Am J Physiol Renal Physiol; 2024 May; 326(5):F780-F791. PubMed ID: 38482553
[TBL] [Abstract][Full Text] [Related]
11.
Bierzynska A; Soderquest K; Dean P; Colby E; Rollason R; Jones C; Inward CD; McCarthy HJ; Simpson MA; Lord GM; Williams M; Welsh GI; Koziell AB; Saleem MA; ;
J Am Soc Nephrol; 2017 May; 28(5):1614-1621. PubMed ID: 27932480
[TBL] [Abstract][Full Text] [Related]
12. NPHS2 gene mutations in azerbaijani children with steroid-resistant nephrotic syndrome.
Baylarov R; Senol O; Atan M; Berdeli A
Saudi J Kidney Dis Transpl; 2020; 31(1):144-149. PubMed ID: 32129207
[TBL] [Abstract][Full Text] [Related]
13. Causal and putative pathogenic mutations identified in 39% of children with primary steroid-resistant nephrotic syndrome in South Africa.
Nandlal L; Winkler CA; Bhimma R; Cho S; Nelson GW; Haripershad S; Naicker T
Eur J Pediatr; 2022 Oct; 181(10):3595-3606. PubMed ID: 35920919
[TBL] [Abstract][Full Text] [Related]
14. WT1 and NPHS2 gene mutation analysis and clinical management of steroid-resistant nephrotic syndrome.
Ramanathan AS; Vijayan M; Rajagopal S; Rajendiran P; Senguttuvan P
Mol Cell Biochem; 2017 Feb; 426(1-2):177-181. PubMed ID: 27885584
[TBL] [Abstract][Full Text] [Related]
15. Exploring the relevance of NUP93 variants in steroid-resistant nephrotic syndrome using next generation sequencing and a fly kidney model.
Bierzynska A; Bull K; Miellet S; Dean P; Neal C; Colby E; McCarthy HJ; Hegde S; Sinha MD; Bugarin Diz C; Stirrups K; Megy K; Mapeta R; Penkett C; Marsh S; Forrester N; Afzal M; Stark H; BioResource N; Williams M; Welsh GI; Koziell AB; Hartley PS; Saleem MA
Pediatr Nephrol; 2022 Nov; 37(11):2643-2656. PubMed ID: 35211795
[TBL] [Abstract][Full Text] [Related]
16. Altered expression of Crb2 in podocytes expands a variation of CRB2 mutations in steroid-resistant nephrotic syndrome.
Udagawa T; Jo T; Yanagihara T; Shimizu A; Mitsui J; Tsuji S; Morishita S; Onai R; Miura K; Kanda S; Kajiho Y; Tsurumi H; Oka A; Hattori M; Harita Y
Pediatr Nephrol; 2017 May; 32(5):801-809. PubMed ID: 27942854
[TBL] [Abstract][Full Text] [Related]
17. Treatment with 2,4-Dihydroxybenzoic Acid Prevents FSGS Progression and Renal Fibrosis in Podocyte-Specific
Widmeier E; Airik M; Hugo H; Schapiro D; Wedel J; Ghosh CC; Nakayama M; Schneider R; Awad AM; Nag A; Cho J; Schueler M; Clarke CF; Airik R; Hildebrandt F
J Am Soc Nephrol; 2019 Mar; 30(3):393-405. PubMed ID: 30737270
[TBL] [Abstract][Full Text] [Related]
18. KANK deficiency leads to podocyte dysfunction and nephrotic syndrome.
Gee HY; Zhang F; Ashraf S; Kohl S; Sadowski CE; Vega-Warner V; Zhou W; Lovric S; Fang H; Nettleton M; Zhu JY; Hoefele J; Weber LT; Podracka L; Boor A; Fehrenbach H; Innis JW; Washburn J; Levy S; Lifton RP; Otto EA; Han Z; Hildebrandt F
J Clin Invest; 2015 Jun; 125(6):2375-84. PubMed ID: 25961457
[TBL] [Abstract][Full Text] [Related]
19. NUP133 Controls Nuclear Pore Assembly, Transcriptome Composition, and Cytoskeleton Regulation in Podocytes.
Rogg M; Maier JI; Ehle M; Sammarco A; Schilling O; Werner M; Schell C
Cells; 2022 Apr; 11(8):. PubMed ID: 35455939
[TBL] [Abstract][Full Text] [Related]
20. Genetic testing in steroid-resistant nephrotic syndrome: when and how?
Lovric S; Ashraf S; Tan W; Hildebrandt F
Nephrol Dial Transplant; 2016 Nov; 31(11):1802-1813. PubMed ID: 26507970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
